How to Prevent and Manage Dry Eyes After LASIK Treatment

/0 Comments/in , /by
After undergoing LASIK treatment, it is common to experience dry eyes. This discomfort can be bothersome, but with proper prevention and management techniques, you can help to alleviate or manage the symptoms. *This article is a guideline only is and not to be construed as medical advice. Always contact your eye care doctor with questions and for treatment options.

Understanding Dry Eyes After LASIK 

Before diving into prevention and management techniques, let’s briefly understand why dry eyes occur after LASIK treatment. During the procedure, the cornea is reshaped to improve vision. According to this peer-reviewed article by Tamimi A, et al.“Although the mechanism involved in post-LASIK eye dryness is not clearly understood, flap creation leads to temporal denervation of the cornea, which causes decreased corneal sensitivity, resulting in this condition.”

Prevention Techniques 

To minimize the occurrence of dry eyes after LASIK, consider the following prevention techniques:
  1. Follow Postoperative Instructions: After LASIK surgery, your eye surgeon will provide specific instructions. Follow them diligently, including proper use of prescribed eye drops and medications. These instructions are designed to promote healing and reduce the risk of complications, including dry eyes.
  2. Stay Hydrated: Drinking an adequate amount of water throughout the day can help maintain overall hydration levels, including your tear production. Aim to drink at least 8 glasses of water daily to prevent dry eyes.
  3. Use a Humidifier: Incorporate a humidifier in your living space, especially in dry environments or during winter months. This device adds moisture to the air, preventing excessive evaporation of tears and reducing the likelihood of dry eyes.
  4. Avoid Smoke and Irritants: Smoke and other irritants in the environment can worsen dry eyes. Avoid smoky areas and minimize exposure to air pollutants, such as dust and strong chemicals.

Management Techniques 

If you still experience dry eyes after LASIK, despite preventive measures, try the following management techniques:
  1. Use Artificial Tears: Artificial tears, available over the counter, can provide immediate relief from dry eyes. Choose preservative-free drops and use them as directed or as needed throughout the day.
  2. Blink Regularly: Remember to blink consciously and regularly, especially when engaging in activities that require prolonged focus, such as working on a computer or reading. Blinking helps distribute tears evenly across the surface of your eyes, reducing dryness.
  3. Take Breaks from Screens: If your work involves extensive screen time, take regular breaks to rest your eyes. Looking away from the screen and focusing on distant objects can help reduce eye strain and dryness.
  4. Protect Your Eyes: Wear sunglasses or protective goggles when exposed to windy or dusty environments to shield your eyes from external irritants. This can prevent excessive tear evaporation and further dryness.

Summary

There are many management and preventative options to consider when treating dry eye following LASIK surgery.  By following postoperative instructions, staying hydrated, using a humidifier, avoiding irritants, and implementing artificial tears, blinking exercises, and protective measures, you can alleviate dryness and hopefully enjoy the full benefits of your LASIK procedure. If the symptoms persist or worsen, consult your eye surgeon for further guidance and support. If you experience complications that result in loss of vision, blurriness, glare, halo, photophobia or other complications, there is hope. 100% of post-LASIK ectasia patients who responded to a 2024 BostonSight survey reported improvement in eye health, vision, and quality of life after getting PROSE treatment. PROSE treatment uses specially designed prosthetic devices (scleral lenses) that vault over the corneal surface, creating a reservoir between the cornea and the lens. The reservoir is filled with preservative-free saline to bathe and hydrate the eye all day, providing immediate relief and comfort, and promoting healing. PROSE prosthetic devices also improve vision. Think of the lens as a “new” cornea, which creates the shape of a typical, healthy cornea. This allows light to enter the eye at the correct angle for excellent vision.

A Hero with a Shield – PROSE Treatment for Children

/0 Comments/in , /by

Falls are the leading cause of injury among children. In fact, in the United States alone, more than 8,000 children every day are treated for fall-related injuries in emergency rooms. While broken bones and cuts heal, what happens when the injury is higher stakes, for example threatening long-term sight? This question was answered Recently at BostonSight’s PROSE provider site at LV Prasad Eye Institute (LVPEI) in India.  

A three-year-old child fell from his bed and suffered severe damage to his right eye from a laceration from a metal rod. The child was rushed to the emergency room and underwent scleral tear repair. After follow-ups and further treatment, LVPEI PROSE practitioner, Dr. Manikanda Prabhu, found that the child had significant irregular astigmatism that would continue to impact his vision severely. At that time, Dr. Prabhu decided to initiate a PROSE fitting. The child, who had already been through such a difficult and painful ordeal continued to be courageous throughout the fitting and, today, has his vision significantly restored thanks to a PROSE device.  

“This story is exciting for two reasons,” shares Dr. Prabhu. “First, this is the first time in our LVPEI network that a child this young has been fit with a PROSE device. Second, the significant improvement in visual acuity is noteworthy after an injury such as this. It is a reminder for us of the many applications where PROSE can make a difference This young patient was so brave and is a hero with his shield, guarding his eye.” 

 

 

  

Eye Ointment Product Recall

/0 Comments/in , , /by
Thane, Maharashtra, India, Brassica Pharma Pvt. Ltd. is voluntarily recalling Eye Ointment products listed in the table below with expiration date ranging from February 2024 to September 2025. The products are being recalled due to lack of sterility assurance at the facility noted during an inspection conducted by the Food and Drug Administration (FDA). Company Announcement Date: February 22, 2024 FDA Publish Date: February 26, 2024 Product Type: Drugs Reason for Announcement: Due to Potential Lack of Sterility Assurance. Company Name: Brassica Pharma Pvt. Ltd. Brand Name: Multiple brands Product Description: Eye ointment products

Company Announcement

FOR IMMEDIATE RELEASE – 12 February, 2024 – Thane, Maharashtra, India, Brassica Pharma Pvt. Ltd. is voluntarily recalling Eye Ointment products listed in the table below with expiration date ranging from February 2024 to September 2025. The products are being recalled due to lack of sterility assurance at the facility noted during an inspection conducted by the Food and Drug Administration (FDA). Risk Statement: For those patients who use these products, there is a potential risk of eye infections or related harm. These products are intended to be sterile. Ophthalmic drug products pose a potential heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses. To date, Brassica Pharma Pvt. Ltd. has not received any reports of adverse events up to 16th February 2024 related to this recall.  
Product Name Package Description Brand Name NDC Lot# Exp Date Exp Date
Equate Lubricant Eye Ointment (Mineral Oil 42.5%, White Petrolatum 57.3%, Lanolin Alcohols) 3.5 gram tube, packaged in cardboard box with UPC Code 681131395298 Equate 79903-026-35 A2E01 Apr-24
A2L05 Nov-24
A3B01 Jan-25
A3C01 Feb-25
A3H05 Jul-25
Equate Stye Lubricant Eye Ointment (Mineral Oil 31.9%, White Petrolatum 57.7%, Microcrystalline Wax, Stearic Acid, Wheat Germ Oil) 3.5 gram tube, packaged in cardboard box with UPC Code 681131395304 Equate 79903- 028-35 A2D08 Mar-24
A2F02 May-24
A2I03 Aug-24
A2L03 Nov-24
A2L04 Nov-24
A3C03 Feb-25
A3C05 Feb-25
A3H01 Jul-25
A3H03 Jul-25
CVS Health Lubricant Eye Ointment (Mineral Oil 31.9%, White Petrolatum 57.7%, Microcrystalline Wax, Stearic Acid Wheat Germ Oil 3.5 gram tube, packaged in cardboard box with UPC Code 050428634141 CVS Health 76168- 707-35 A2F03 May-24
A2I02 Aug-24
A2L02 Nov-24
A3C04 Feb-25
A3H04 Jul-25
Lubricant PM Ointment 3.5 gram tube, packaged in cardboard box with UPC Code 371406124356 AACE Pharmaceuticals 71406- 124-35 A2G01 Jun-24
A2G02 Jun-24
A3F08 May-25
A3F09 May-25
A3J17 Sep-25
A3J18 Sep-25
These products were distributed nationwide to wholesalers, retailers, and via the product distributor, Walmart, CVS and AACE Pharmaceuticals Inc. Brassica Pharma Pvt. Ltd. Is notifying its distributors AACE Pharmaceuticals Inc and its retailers Walmart and CVS. These distributors shall be further notifying the wholesalers and retailers via mail of this voluntary recall and arranging for return of all impacted products listed above. Consumers, distributors and retailers that have any product which is being recalled should cease distribution of the product. Consumers should stop using the recalled Eye Ointment and may return any of the above listed products to the place of purchase. Consumers with questions regarding this recall can contact Brassica Pharma Pvt. Ltd. at +1 833-225-9564 or info@brassicapharma.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Understanding Ocular GVHD: A Comprehensive Guide

/0 Comments/in , /by
*This article is a guideline only and not to be construed as medical advice. Always contact your eye care doctor with questions and for treatment options. Ocular Graft-versus-Host Disease (GVHD) is a complex condition that can significantly impact the eyes of individuals who have undergone hematopoietic stem cell transplantation. This comprehensive guide aims to provide valuable insights into ocular GVHD, covering its causes, symptoms, diagnosis, and management.

What is Ocular GVHD? 

Ocular GVHD is a manifestation of graft-versus-host disease, a common complication that arises after stem cell or bone marrow transplantation. In this condition, the donor’s immune cells attack the recipient’s tissues, leading to inflammation and damage in various organs, including the eyes.

Causes and Risk Factors 

Understanding the causes and risk factors of ocular GVHD is crucial for both patients and healthcare professionals. The primary trigger is the transplantation process itself, where the immune cells from the donor recognize the recipient’s tissues as foreign and initiate an immune response. Other risk factors include the type of transplant, age, and the presence of pre-existing ocular conditions.

Symptoms of Ocular GVHD 

Recognizing the symptoms of ocular GVHD is vital for early intervention. Common symptoms include dry eyes, redness, light sensitivity, blurred vision, pain, and a gritty or burning sensation. Patients may also experience excessive tearing or mucous discharge.

Diagnosis 

Accurate diagnosis is essential for effective management. Ophthalmologists play a key role in diagnosing ocular GVHD by conducting a thorough eye examination, assessing symptoms, and utilizing advanced diagnostic tools such as tear film analysis and corneal imaging.

Treatment and Management

Managing ocular GVHD requires a multidisciplinary approach involving ophthalmologists, hematologists, and other healthcare professionals. Treatment strategies focus on alleviating symptoms and controlling inflammation. Artificial tears, anti-inflammatory medications, and immunosuppressive drugs are commonly prescribed. Specialty lenses may also be used. If you have ocular GVHD, you do not need to suffer. PROSE treatment may be a good solution for you. PROSE treatment uses specially designed prosthetic scleral lenses that vault over the corneal surface, creating a reservoir between the cornea and the lens. The reservoir is filled with preservative-free saline to bathe and hydrate the eye all day, providing relief and comfort, and promoting healing. PROSE prosthetic lenses also provide improved vision. Think of the lens as a “new” cornea, which creates the shape of a typical, healthy cornea. This allows light to enter the eye at the correct angle for excellent vision.

Lifestyle Modifications 

Patients with ocular GVHD can adopt certain lifestyle modifications to enhance their eye health. Strategies include using humidifiers, avoiding environmental irritants, and practicing proper eye hygiene. Regular follow-up appointments with healthcare providers are crucial to monitor progress and adjust treatment plans accordingly.

Support and Coping Mechanisms 

Living with ocular GVHD can be challenging, both physically and emotionally. Support groups, counseling, and educational resources can help patients and their families cope with the impact of this condition. Connecting with others who share similar experiences can provide valuable insights and emotional support. In conclusion, ocular GVHD is a complex condition that requires a comprehensive understanding for effective management. By recognizing the causes, symptoms, and available treatment options, individuals affected by ocular GVHD can work collaboratively with their healthcare providers to improve their quality of life.  

The Impact of Ocular GVHD on Quality of Life

/0 Comments/in , /by
*This article is a guideline only and not to be construed as medical advice. Always contact your eye care doctor with questions and for treatment options. Ocular Graft-versus-Host Disease (GVHD) is a complex and challenging condition that arises as a complication of allogeneic hematopoietic stem cell transplantation. This condition affects the eyes, leading to a range of symptoms that can significantly impact the quality of life of affected individuals. In this article, we delve into the intricate details of ocular GVHD and its profound implications on the well-being of patients.

Understanding Ocular GVHD 

Ocular GVHD occurs when donor immune cells recognize the recipient’s tissues as foreign and mount an attack. This immune response targets the ocular surface, resulting in inflammation, damage to the cornea, and a host of ocular symptoms. Common symptoms include dry eyes, blurred vision, light sensitivity, and chronic eye discomfort.

Quality of Life Impact 

  1. Persistent Discomfort: Ocular GVHD is often accompanied by persistent discomfort, ranging from a gritty sensation to a burning or stabbing pain. These symptoms can significantly reduce an individual’s overall comfort and well-being, impacting daily activities and productivity.
  2. Visual Impairment: The condition can lead to visual impairment, making it challenging for patients to perform routine tasks such as reading, driving, or using digital devices. The resulting dependency on others for assistance can contribute to feelings of frustration and loss of independence.
  3. Emotional Toll: Coping with chronic ocular symptoms can take a toll on an individual’s mental health. The emotional burden of dealing with a condition that affects one’s vision and daily activities can lead to anxiety, depression, and a diminished quality of life.
  4. Social Impact: Ocular GVHD can also affect social interactions. Individuals may withdraw from social activities due to discomfort or embarrassment about visible symptoms like redness or tearing. This social isolation can further exacerbate the emotional challenges associated with the condition.

Management Strategies 

  1. Topical Therapies: ocular GVHD management often involves topical therapies such as lubricating eye drops, anti-inflammatory medications, and immunosuppressive agents. These treatments aim to alleviate symptoms and improve overall ocular health.
  2. Multidisciplinary Approach: A multidisciplinary approach involving ophthalmologists, hematologists, and other healthcare professionals is crucial for comprehensive ocular GVHD management. This ensures a holistic assessment of the patient’s condition and the development of personalized treatment plans.
  3. Treatment Strategies: Strategies focus on alleviating symptoms and controlling inflammation. Artificial tears, anti-inflammatory medications, and immunosuppressive drugs are commonly prescribed. Specialty lenses may also be used. If you have ocular GVHD, you do not need to suffer. PROSE treatment may be a good solution for you. PROSE uses specially designed scleral lenses that vault over the entire corneal surface and create a reservoir between the cornea and the lens. The reservoir is filled with preservative-free saline to bathe and hydrate the eye all day, providing relief and comfort, and promoting healing.
  4. Patient Education and Support: Providing patients with adequate information about their condition, treatment options, and potential outcomes is essential. Support groups and counseling services can also play a crucial role in helping individuals cope with the emotional and social challenges associated with ocular GVHD.
In conclusion, ocular GVHD is more than just a medical condition; it is a complex interplay of physical, emotional, and social factors that significantly impact an individual’s quality of life. By understanding the multifaceted nature of this condition and adopting a comprehensive approach to management, healthcare professionals can contribute to improving the overall well-being of patients affected by ocular GVHD.

Managing Ocular GVHD: Tips and Strategies for Patients 

/0 Comments/in , /by
*This article is a guideline only and not to be construed as medical advice. Always contact your eye care doctor with questions and for treatment options. Ocular Graft-versus-Host Disease (GVHD) is a challenging condition that affects the eyes of individuals who have undergone allogeneic hematopoietic stem cell transplantation. It occurs when transplanted immune cells recognize the recipient’s tissues as foreign and attack them. Managing ocular GVHD requires a multifaceted approach to alleviate symptoms and improve overall eye health. In this article, we’ll explore effective tips and strategies for patients grappling with this condition.

Understanding Ocular GVHD 

Before delving into management strategies, it’s essential to comprehend the symptoms associated with ocular GVHD. Common signs include dry eyes, redness, light sensitivity, blurred vision, pain, and a gritty or burning sensation. The severity of these symptoms can vary, making personalized management crucial for each patient.

Regular Eye Exams

Routine eye examinations play a pivotal role in managing ocular GVHD. Patients should schedule regular appointments with their ophthalmologist to monitor any changes in their eye health. Early detection of complications can lead to more effective interventions, minimizing potential damage.

Lubricating Eye Drops

One of the primary complaints in ocular GVHD patients is dry eyes. Lubricating eye drops, artificial tears, and gels can provide relief by moisturizing the eyes and alleviating discomfort. Patients should use preservative-free formulations to prevent irritation.

Prescription Medications

For more severe cases, ophthalmologists may prescribe medications such as cyclosporine eye drops or corticosteroids to manage inflammation and immune responses. These medications aim to suppress the immune system locally, reducing the impact of GVHD on the eyes.

Warm Compresses and Lid Hygiene

Warm compresses and lid hygiene can help manage symptoms like redness and irritation. Applying a warm compress to the eyes can improve oil gland function, easing discomfort. Additionally, gentle lid hygiene using mild cleansers can prevent complications related to bacterial infections.

Nutritional Support

Maintaining a diet rich in omega-3 fatty acids, vitamins A and D, and other antioxidants may contribute to overall eye health. Nutritional supplements may also be recommended to support tear production and alleviate symptoms of ocular GVHD. Always discuss with your ophthalmologist and oncologist before starting any dietary changes or supplements.

UV Protection

Light sensitivity is a common issue in ocular GVHD patients. Wearing sunglasses with UV protection can shield the eyes from harmful rays and reduce discomfort caused by bright lights. Wraparound styles provide additional coverage.

Environmental Modifications

Patients can make environmental changes to reduce eye strain and irritation. Using a humidifier to maintain optimal humidity levels, avoiding smoke and air pollutants, and taking breaks during extended screen time can contribute to a more comfortable environment for ocular GVHD patients.

Medical Treatments

Treatment strategies focus on alleviating symptoms and controlling inflammation. Artificial tears, anti-inflammatory medications, and immunosuppressive drugs are commonly prescribed. Specialty lenses may also be used. If you have ocular GVHD, you do not need to suffer. PROSE treatment may be a good solution for you. PROSE treatment uses specially designed prosthetic scleral lenses that vault over the corneal surface, creating a reservoir between the cornea and the lens. The reservoir is filled with preservative-free saline to bathe and hydrate the eye all day, providing relief and comfort, and promoting healing. PROSE prosthetic lenses also provide improved vision. Think of the lens as a “new” cornea, which creates the shape of a typical, healthy cornea. This allows light to enter the eye at the correct angle for excellent vision. Managing ocular GVHD requires a comprehensive approach that considers individual symptoms and their severity. By incorporating regular eye exams, lubricating eye drops, prescription medications, warm compresses, nutritional support, UV protection, environmental modifications, and medical treatments, patients can effectively alleviate discomfort and maintain better eye health. Individuals with ocular GVHD must work closely with their healthcare team to develop a personalized management plan that addresses their unique needs and enhances their quality of life.

Navigating Ocular GVHD in Pediatric Patients: Overcoming Challenges and Essential Considerations

/0 Comments/in , /by
*This article is a guideline only and not to be construed as medical advice. Always contact your eye care doctor with questions and for treatment options. Ocular Graft-versus-Host Disease (GVHD) poses unique challenges when it affects pediatric patients. This condition arises as a complication of allogeneic hematopoietic stem cell transplantation, where the donor’s immune cells attack the recipient’s tissues, including the eyes. Managing ocular GVHD in children requires a specialized approach due to their distinct needs and considerations. In this blog post, we’ll explore the challenges associated with ocular GVHD in pediatric patients and discuss crucial considerations for effective management.

Understanding Ocular GVHD

Ocular GVHD manifests as a chronic, immune-mediated disorder affecting the ocular surface. In pediatric cases, it presents an added layer of complexity, as children may have difficulty expressing their symptoms, making early diagnosis and intervention challenging.

Challenges in Pediatric Cases 

  1. Communication Barriers: Children may struggle to articulate their symptoms or discomfort, making it crucial for healthcare providers to adopt a comprehensive approach that involves parents, caregivers, and age-appropriate communication techniques.
  2. Symptom Recognition: Ocular GVHD symptoms can overlap with other eye conditions, complicating diagnosis. Redness, dryness, light sensitivity, and blurred vision may be attributed to various factors, necessitating a keen eye for subtle signs.
  3. Treatment Compliance: Pediatric patients may find it challenging to adhere to complex treatment regimens. Balancing the efficacy of therapies with their impact on a child’s daily life is vital for long-term success.

Considerations for Pediatric Ocular GVHD Management

  1. Multidisciplinary Approach: Collaboration between pediatricians, ophthalmologists, and hematologists is crucial for a comprehensive approach. Regular check-ups should include assessments of ocular health alongside general health examinations.
  2. Early Intervention: Timely diagnosis is key. Regular eye examinations, especially for children who have undergone stem cell transplantation, can help identify ocular GVHD in its early stages, improving the chances of successful intervention.
  3. Tailored Treatment Plans: Customizing treatment plans to suit the unique needs of pediatric patients is essential. Topical steroids, lubricating eye drops, and systemic immunosuppressive medications may be employed, with careful consideration given to potential side effects in growing children. Specialty lenses may also be used. PROSE treatment may be a good solution for children. PROSE uses specially designed scleral lenses of varying sizes to vault the corneal surface and create a reservoir between the cornea and the lens. The reservoir is filled with preservative-free saline to bathe and hydrate the eye all day, providing immediate relief and comfort, and promoting healing.
  4. Educating Parents and Caregivers: Empowering parents and caregivers with knowledge about ocular GVHD symptoms and the importance of regular eye check-ups can facilitate early intervention and ongoing management.
  5. Psychosocial Support: Recognizing the emotional impact of ocular GVHD on pediatric patients and their families is crucial. Offering psychosocial support services can help them cope with the challenges associated with chronic illness.

Conclusion

Effectively managing ocular GVHD in pediatric patients requires a tailored, multidisciplinary approach that addresses the unique challenges associated with this condition in children. By fostering collaboration among healthcare providers, prioritizing early intervention, and considering the specific needs of pediatric patients, we can enhance the quality of life for these young individuals battling ocular GVHD.

Ocular GVHD Symptoms and Warning Signs: What to Look For

/0 Comments/in , /by
*This article is a guideline only and not to be construed as medical advice. Always contact your eye care doctor with questions and for treatment options. Ocular Graft-versus-Host Disease (GVHD) is a serious condition that can affect individuals who have undergone allogeneic hematopoietic stem cell transplantation. While the disease primarily targets the eyes, its symptoms can often go unnoticed in the early stages. In this blog post, we’ll delve into the crucial information you need to recognize the warning signs of ocular GVHD and seek timely medical intervention. Understanding Ocular GVHD  Ocular GVHD occurs when transplanted immune cells attack the recipient’s eye tissues, leading to inflammation and damage. Recognizing the symptoms early on is vital for effective management and prevention of complications. Symptoms and Warning Signs of Ocular GVHD 
  1. Dry Eyes: Ocular GVHD often manifests as severe dry eyes, causing discomfort and blurred vision.
  2. Redness, Irritation, and Eye Pain: Persistent redness, irritation, and pain may be potential indicators of ocular GVHD.
  3. Light Sensitivity: Increased sensitivity to light can be an overlooked symptom of ocular GVHD.
  4. Blurred Vision: If you notice sudden or gradual blurred vision, it’s crucial to consider ocular GVHD as a possible cause.
Treatment and Management 
  1. Regular Eye Exams: Routine eye exams are essential for early detection; make them a priority, especially if you’re at risk. Seek advice from ophthalmologists experienced in managing ocular GVHD for a comprehensive evaluation.
  2. Immunosuppressive Therapy: Understand how immunosuppressive medications can help control the immune response and minimize eye damage.
  3. Lifestyle Modifications: Lifestyle changes can complement medical treatments and alleviate ocular GVHD symptoms.
  4. Solutions: Treatment strategies focus on alleviating symptoms and controlling inflammation. Artificial tears, anti-inflammatory medications, and immunosuppressive drugs are commonly prescribed. Specialty lenses may also be used. If you have ocular GVHD, you do not need to suffer. PROSE treatment uses specially designed prosthetic scleral lenses that vault over the corneal surface, creating a reservoir between the cornea and the lens. The reservoir is filled with preservative-free saline to bathe and hydrate the eye all day, providing relief and comfort, and promoting healing. PROSE prosthetic lenses also provide improved vision. Think of the lens as a “new” cornea, which creates the shape of a typical, healthy cornea. This allows light to enter the eye at the correct angle for excellent vision.
Conclusion Early recognition of ocular GVHD symptoms is crucial for effective management and improved outcomes. By staying informed about the warning signs and seeking prompt medical attention, individuals at risk can take proactive steps towards preserving their eye health. Don’t underestimate the significance of regular eye check-ups, especially if you’ve undergone stem cell transplantation. Your vision is worth the vigilance.